Clinical trial
Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer
NCT00003219 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00003219 |
|---|---|
| Title | Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer |
| Official title | A Phase II Trial of Perillyl Alcohol (NSC 641066) Administered Daily in Patients With Metastatic Breast Cancer |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | perillyl alcohol |
| Start date | May 1, 1998 |
| Primary completion | May 1, 1998 |
| Completion | May 1, 1998 |
| First posted | Jul 19, 2004 |
| Last update posted | Dec 13, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: